Related Experiment Video
Updated: Feb 14, 2026

A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars
Published on: March 15, 2017
Histamine as an emergent indoor contaminant: Accumulation and persistence in bed bug infested homes
Zachary C DeVries1,2, Richard G Santangelo1, Alexis M Barbarin3
1Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, United States of America.
Abstract:
Histamine is used in bronchial and dermal provocation, but it is rarely considered an environmental risk factor in allergic disease. Because bed bugs defecate large amounts of histamine as a component of their aggregation pheromone, we sought to determine if histamine accumulates in household dust in bed bug infested homes, and the effects of bed bug eradication with spatial heat on histamine levels in dust. We collected dust in homes and analyzed for histamine before, and up to three months after bed bug eradication. Histamine levels in bed bug infested homes were remarkably high (mean = 54.6±18.9 μg/100 mg of sieved household dust) and significantly higher than in control homes not infested with bed bugs (mean < 2.5±1.9 μg/100 mg of sieved household dust). Heat treatments that eradicated the bed bug infestations failed to reduce histamine levels, even three months after treatment. We report a clear association between histamine levels in household dust and bed bug infestations. The high concentrations, persistence, and proximity to humans during sleep suggest that bed bug-produced histamine may represent an emergent contaminant and pose a serious health risk in the indoor environment.
Related Concept Videos
Capillary Beds
Capillaries connect arterioles, small branches of arteries, to venules,...
Emerging Adulthood
Contaminants and Errors
Another key consideration is determining the appropriate number of samples required to...
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

